Caffeine Oral Solution

Caffeine Oral Solution is a prescription neonatal medicine used for the treatment of apnoea of prematurity in premature newborns. Depending on the specific product, the active ingredient may be expressed as caffeine or caffeine citrate, so the exact strength should always be matched to the product label.

Product Information

• Active Ingredient: Caffeine or caffeine citrate, depending on product
• Dosage Form: Oral Solution / Oral Liquid
• Route: Oral
• Drug Class: Methylxanthine / CNS stimulant
• Primary Clinical Use: Apnoea of prematurity
• Prescription: Yes
• Common Marketed Strength: 20mg/mL for caffeine citrate products

Important Strength Difference

For products labeled caffeine citrate 20mg/mL, the concentration corresponds to 10mg/mL caffeine base. This must not be confused with a product labeled as 20mg/mL caffeine base. The exact product formulation should be confirmed before publication or ordering.

Main Uses

Medicinal caffeine citrate oral solution is used for primary apnoea of premature newborns and is administered under appropriate neonatal medical supervision.

Commercial Availability

Commercial searches include buy caffeine oral solution, caffeine oral solution price, caffeine citrate oral solution 20mg/mL, caffeine citrate oral liquid, neonatal caffeine oral solution and caffeine citrate for apnoea of prematurity. Current U.S. products include caffeine citrate oral solution at 20mg/mL, while Indian products such as Apnicaf are currently marketed as caffeine 20mg/mL oral solution.

Product strength, active-substance expression, pack size and regulatory status vary by manufacturer and country.

Safety

Caffeine oral solution for premature newborns requires medical supervision. Other causes of neonatal apnoea should be assessed before treatment, and appropriate monitoring is required during therapy.